The high incidence of recurrence after an initial stone event underscores t
he need for an effective medical prophylactic program. Dietary modification
and drug therapies have long been advocated to reduce the likelihood of st
one recurrence. While the efficacy of a high fluid intake has been validate
d in a randomized trial, the benefit of other dietary measures is based on
modulation of urinary stone risk factors and outcomes derived from observat
ional studies. Several drug therapies have been evaluated in a limited numb
er of prospective, randomized trials and efficacy has been demonstrated for
thiazides, allopurinol and alkali citrate in some populations of recurrent
stone formers. The role of selective versus nonselective therapy for stone
prevention awaits further study. Curr Opin Nephrol Hypertens 10:203-209. (
C) 2001 Lippincott Williams & Wilkins.